A Neutralizing Anti-gH/gL Monoclonal Antibody Is Protective in the Guinea Pig Model of Congenital CMV Infection

作者：Auerbach Marcy R; Yan Donghong; Vij Rajesh; Hongo Jo Anne; Nakamura Gerald; Vernes Jean Michel; Meng Y Gloria; Lein Samantha; Chan Pamela; Ross Jed; Carano Richard; Deng Rong; Lewin Koh Nicholas; Xu Min; Feierbach Becket^*

来源：PLoS Pathogens, 2014, 10(4): e1004060.

DOI：10.1371/journal.ppat.1004060

Human cytomegalovirus (HCMV) is the most common cause of congenital virus infection. Congenital HCMV infection occurs in 0.2-1% of all births, and causes birth defects and developmental abnormalities, including sensorineural hearing loss and developmental delay. Several key studies have established the guinea pig as a tractable model for the study of congenital HCMV infection and have shown that polyclonal antibodies can be protective [1-3]. In this study, we demonstrate that an anti-guinea pig CMV (GPCMV) glycoprotein H/glycoprotein L neutralizing monoclonal antibody protects against fetal infection and loss in the guinea pig. Furthermore, we have delineated the kinetics of GPCMV congenital infection, from maternal infection (salivary glands, seroconversion, placenta) to fetal infection (fetus and amniotic fluid). Our studies support the hypothesis that a neutralizing monoclonal antibody targeting an envelope GPCMV glycoprotein can protect the fetus from infection and may shed light on the therapeutic intervention of HCMV congenital infection in humans.

• 出版日期2014-4